Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae

[1]  E. Pérez-Nadales,et al.  External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance. , 2019, International journal of antimicrobial agents.

[2]  O. Ergonul,et al.  The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  N. Petrosillo,et al.  Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future , 2019, Journal of clinical medicine.

[4]  Tae Hyong Kim,et al.  Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea , 2019, Antimicrobial Resistance & Infection Control.

[5]  D. Falci,et al.  Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection. , 2019, International journal of antimicrobial agents.

[6]  Banu Kaskatepe,et al.  High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey. , 2018, Acta microbiologica et immunologica Hungarica.

[7]  G. Daikos,et al.  Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis. , 2018, International journal of antimicrobial agents.

[8]  M. Parlak,et al.  Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance. , 2018, Microbial drug resistance.

[9]  M. Gönen,et al.  Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection , 2018, The Journal of antimicrobial chemotherapy.

[10]  Ö. Ergönül,et al.  Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. , 2017, The Journal of hospital infection.

[11]  E. Alp,et al.  Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance? , 2017, Microbial drug resistance.

[12]  A. Oliver,et al.  Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. , 2017, The Lancet. Infectious diseases.

[13]  E. Pérez-Nadales,et al.  Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems , 2017, Antimicrobial Agents and Chemotherapy.

[14]  Kaye,et al.  Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality , 2017 .

[15]  M. Bassetti,et al.  Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Bassetti,et al.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. , 2015, The Journal of antimicrobial chemotherapy.

[17]  A. Tsakris,et al.  Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates , 2015, Antimicrobial Agents and Chemotherapy.

[18]  A. Pantosti,et al.  Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  Bilgul Mete,et al.  Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[20]  Ju-Yeun Lee,et al.  Colistin resistance in Klebsiella pneumoniae. , 2014, International journal of antimicrobial agents.

[21]  V. Miriagou,et al.  Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems , 2014, Antimicrobial Agents and Chemotherapy.

[22]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[23]  N. Petrosillo,et al.  Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art , 2013, Expert review of anti-infective therapy.

[24]  A. Carattoli,et al.  High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  M. Bassetti,et al.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Pournaras,et al.  Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  Jian Li,et al.  Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.

[28]  P. Della‐Latta,et al.  Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. , 2010, Diagnostic microbiology and infectious disease.

[29]  M. Adams,et al.  Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.

[30]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[31]  M. Falagas,et al.  Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study , 2008, Critical care medicine.

[32]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .